Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Physiomics ( (GB:PYC) ) has issued an announcement.
Physiomics PLC has announced a change in major holdings, indicating a shift in the company’s shareholder structure. Ryan Mancrief has sold his holdings at Barclays Investment Solutions Limited, now holding 14,234,711 shares in a nominee account at AJ Bell plc, which represents 4.6947% of the company’s issued share capital. This change reflects a decrease from a previous position of 8.5127% and may impact the company’s voting dynamics and influence among stakeholders.
More about Physiomics
Physiomics PLC operates in the biotechnology industry, focusing on providing computational biology services. Its primary products and services are designed to optimize drug discovery and development processes, with a market focus on pharmaceutical companies seeking to enhance their research and development efficiency.
YTD Price Performance: -33.33%
Average Trading Volume: 4,749,818
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.59M
For detailed information about PYC stock, go to TipRanks’ Stock Analysis page.
